Therapeutic Strategies to Overcome Payload Resistance of Trastuzumab Deruxtecan in HER2 ‐Positive Cancers

医学 药理学 癌症研究 Abcg2型 癌症 基因敲除 下调和上调 抗药性 曲妥珠单抗 肺癌 流出 克里唑蒂尼 癌细胞 药品 ATP结合盒运输机 P-糖蛋白 DU145型 序号38 细胞培养 阿霉素
作者
Yuya Murase,Shigeki Nanjo,Sachiko Arai,Sota Kondo,Hayato Koba,Liu Yifeng,Koji Fukuda,Shigeki Sato,Jun Kinoshita,Noriyuki Inaki,Tsukasa Ueda,Shunichi Nomura,Yuichi Tambo,Takahiro Shimizu,Masafumi Horie,Daichi Maeda,Richard Wing-Chuen Wong,Kazuyoshi Hosomichi,T Kobayashi,Satoshi Watanabe
出处
期刊:Cancer Science [Wiley]
卷期号:117 (4): 996-1009 被引量:11
标识
DOI:10.1111/cas.70319
摘要

Antibody-drug conjugates (ADCs) are emerging as a promising class of targeted cancer therapy. Trastuzumab deruxtecan (T-DXd), a human epidermal growth factor receptor 2 (HER2)-directed ADC, has demonstrated clinical efficacy in HER2-positive gastric and breast cancers, as well as in HER2-mutant non-small cell lung cancer. However, the development of acquired resistance limits their long-term efficacy. To elucidate the resistance mechanism, we established T-DXd-resistant cell lines derived from HER2-amplified gastric xenografts (N87 acquired resistance [AR]) and leptomeningeal carcinomatosis (Calu-3 AR) lung cancer cells. N87 AR cells exhibited cross-resistance to T-DXd, payload DXd, and topoisomerase I inhibitor SN-38 despite preserved HER2 expression and intact drug internalization. As payload resistance-related molecules, ATP-binding cassette (ABC) transporter ABCG2 and ABCB1 were markedly upregulated in N87 AR and Calu-3 cells, respectively. Inhibition of ABCG2 and ABCB1 in N87 AR and Calu-3 cells, respectively, through siRNA-mediated knockdown restored T-DXd sensitivity in both models. As a strategy to overcome resistance, pharmacological inhibitors of ABCG2 and ABCB1 restored the T-DXd sensitivity of N87 AR and Calu-3 cells, respectively. Moreover, BB-1701, a novel HER2-ADC containing eribulin as a payload, to which N87 AR cells are sensitive, exhibited antitumor effects in N87 AR cells in vitro and in vivo. These findings indicate that ABC transporter-mediated drug efflux is an important mechanism underlying T-DXd resistance in HER2-positive gastric and lung cancer models. Furthermore, our study suggests that both targeting drug efflux pathways and utilizing alternative payloads may be effective strategies for overcoming T-DXd resistance in HER2-positive gastric and lung cancers.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
赘婿的应助被Huangcc采纳,获得10
2秒前
抽烟酒牲发布了新的文献求助10
3秒前
田様的应助被洋芋采纳,获得10
3秒前
CipherSage的应助被hmx采纳,获得10
3秒前
3秒前
李富杰完成签到,获得积分10
3秒前
北极星完成签到 ,获得积分10
4秒前
4秒前
sks110关注了科研通微信公众号
4秒前
沉静方盒发布了新的文献求助10
5秒前
1111完成签到,获得积分10
5秒前
mnbvcxz完成签到,获得积分10
5秒前
爱学习小羊完成签到 ,获得积分10
6秒前
6秒前
溪岸叶落的应助被QQ采纳,获得10
6秒前
xinxin发布了新的文献求助10
7秒前
科研通AI6.3的应助被尺八采纳,获得10
7秒前
JamesPei的应助被陶醉白梅采纳,获得10
8秒前
8秒前
在水一方的应助被龙哥采纳,获得10
8秒前
打打的应助被从容的半蕾采纳,获得10
9秒前
lijia完成签到,获得积分10
9秒前
慕青的应助被清狂采纳,获得10
10秒前
积极向上完成签到,获得积分0
10秒前
yhy发布了新的文献求助10
10秒前
10秒前
11秒前
12秒前
sunziyi发布了新的文献求助10
13秒前
13秒前
小马甲的应助被zdenglong采纳,获得10
14秒前
Monster完成签到,获得积分20
14秒前
14秒前
山北大花萼完成签到,获得积分10
15秒前
乐乐的应助被小饭采纳,获得10
15秒前
zch完成签到,获得积分10
16秒前
16秒前
秋风的应助被吱吱采纳,获得10
16秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188177
求助须知:如何正确求助?哪些是违规求助? 9575987
关于积分的说明 21844723
捐赠科研通 7785975
什么是DOI,文献DOI怎么找? 3435220
关于科研通互助平台的介绍 2559558
邀请新用户注册赠送积分活动 2482095